Research Article

Role of the kidney in regulating plasma immunoreactive beta-melanocyte-stimulating hormone.

Br Med J 1976; 1 doi: http://dx.doi.org/10.1136/bmj.1.6014.874 (Published 10 April 1976) Cite this as: Br Med J 1976;1:874
  1. A G Smith,
  2. S Shuster,
  3. A J Thody,
  4. F Alvarez-Ude,
  5. D N Kerr

    Abstract

    An analysis of the factors that influence the increase in plasma immunoreactive beta-melanocyte-stimulating hormone (beta-MSH) concentration in chronic renal failure showed that: (a) the increase correlated with the increase in serum creatinine concentrations; (b) beta-MSH was not cleared from the plasma by haemodialysis; (c) beta-MSH concentrations increased with length of time on dialysis and increased further after bilateral nephrectomy but there was no further increase with time; (d) beta-MSH levels decreased to normal after renal transplantation; and (e) beta-MSH was excreted in urine only when plasma levels rose to well above those of chronic renal failure (in Nelson's syndrome). These findings suggest that the kidney regulated plasma beta-MSH by a non-excretory mechanism and is the major site of beta-MSH metabolism.